TTAB Oppositions 91216071
USPTO Oppositions proceeding 91216071, filed 2014-04-24. Status: Terminated.
Proceeding Facts
| Proceeding Number | 91216071 |
|---|---|
| Type | Oppositions |
| Status | Terminated |
| Filing Date | 2014-04-24 |
| Last Activity | 2015-01-22 |
| Days Active | 4403 |
Parties
- Actavis, Inc. — Defendant
- Genentech, Inc. — Plaintiff
Plaintiff Marks
- ACTIVASE — Genentech, Inc.
- ACTIVASE ALTEPLASE A RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR THE ONE T-PA FOR STROKE — Genentech, Inc.
- CATHFLO ACTIVASE (ALTEPLASE) THE ONE 2-MG T-PA — Genentech, Inc.
Defendant Marks
- ACTAVIS — Actavis, Inc.
Recent Documents
- 2015-01-22: TERMINATED — Status
- 2015-01-22: BD DECISION: DISMISSED W/O PREJ — Decisions
- 2014-12-11: MOT TO AMEND APPLICATION — Motions
- 2014-11-24: D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
- 2014-11-24: SUSPENDED — Status
- 2014-11-24: STIP TO SUSP PEND SETTL NEGOTIATIONS — Motions
- 2014-08-25: SUSPENDED — Status
- 2014-08-25: STIP TO SUSP PEND SETTL NEGOTIATIONS — Motions
- 2014-06-03: SUSPENDED — Status
- 2014-05-29: STIP TO SUSP PEND SETTL NEGOTIATIONS — Motions
- 2014-04-24: PENDING, INSTITUTED — Status
- 2014-04-24: NOTICE AND TRIAL DATES SENT; ANSWER DUE: — Scheduling
- 2014-04-24: FILED AND FEE — Fees